KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Common Equity (2016 - 2025)

Novartis Ag's Common Equity history spans 13 years, with the latest figure at $46.5 billion for Q4 2025.

  • On a quarterly basis, Common Equity rose 5.68% to $46.5 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $46.5 billion, a 5.68% increase, with the full-year FY2025 number at $46.5 billion, up 5.68% from a year prior.
  • Common Equity hit $46.5 billion in Q4 2025 for Novartis Ag, up from $42.1 billion in the prior quarter.
  • Over the last five years, Common Equity for NVS hit a ceiling of $67.8 billion in Q2 2021 and a floor of $41.9 billion in Q2 2024.
  • Historically, Common Equity has averaged $52.8 billion across 5 years, with a median of $49.3 billion in 2023.
  • Biggest five-year swings in Common Equity: skyrocketed 4879.56% in 2021 and later decreased 21.33% in 2023.
  • Tracing NVS's Common Equity over 5 years: stood at $67.8 billion in 2021, then decreased by 12.38% to $59.4 billion in 2022, then fell by 21.33% to $46.8 billion in 2023, then dropped by 5.78% to $44.0 billion in 2024, then grew by 5.68% to $46.5 billion in 2025.
  • Business Quant data shows Common Equity for NVS at $46.5 billion in Q4 2025, $42.1 billion in Q2 2025, and $44.0 billion in Q4 2024.